Veracyte Analyst Price Targets - Benzinga

Veracyte Inc

VCYTNASDAQ

Trade with Public

Trade with Public

$46.38

0.300.66%

最終更新: Sep 30, 1:35 PM

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Veracyte Analyst Price Targets

Wall Street analyst price targets and consensus rating for Veracyte (VCYT).

Price Target Range — 11 Quarters

Analyst Consensus — 12 Analysts

9Buy

2Hold

1Sell

Consensus RatingBuy# Analysts12Avg. Consensus PT$52Upside to Avg. PT+12.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 15, 2026	Freedom Capital Markets	Keith Hinton	Maintained	Buy	$66
Sep 9, 2026	UBS	Doug Schenkel	PT Raise	Buy	$52→$65
Aug 4, 2026	Piper Sandler	David Westenberg	PT Cut	Overweight	$66→$54
Aug 4, 2026	Stephens & Co.	Mason Carrico	PT Cut	Overweight	$68→$55
Aug 4, 2026	Morgan Stanley	Tejas Savant	PT Cut	Underweight	$47→$44
Aug 3, 2026	Canaccord Genuity	Kyle Mikson	PT Cut	Hold	$60→$50
Jul 31, 2026	Needham	Mike Matson	PT Raise	Buy	$57→$69
Jul 30, 2026	Needham	Mike Matson	PT Raise	Buy	$57→$69
Jul 15, 2026	Piper Sandler	David Westenberg	Initiate	Overweight	$66
Jul 14, 2026	Canaccord Genuity	Kyle Mikson	PT Raise	Hold	$42→$60
Jul 9, 2026	Morgan Stanley	Tejas Savant	PT Raise	Underweight	$37→$47
Jun 29, 2026	Guggenheim	Subbu Nambi	PT Raise	Buy	$45→$65
Jun 1, 2026	Needham	Mike Matson	PT Raise	Buy	$48→$57
May 28, 2026	Needham	Mike Matson	Maintained	Buy	$48
May 6, 2026	Canaccord Genuity	Kyle Mikson	PT Raise	Hold	$40→$42
May 6, 2026	UBS	Lu Li	PT Raise	Buy	$48→$52
Apr 20, 2026	Canaccord Genuity	Kyle Mikson	PT Cut	Hold	$43→$40
Apr 13, 2026	Jefferies	Tycho Peterson	Initiate	Buy	$45
Apr 1, 2026	Needham	Mike Matson	Maintained	Buy	$48
Mar 30, 2026	Guggenheim	Subbu Nambi	PT Cut	Buy	$50→$45

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Buy on Veracyte, Raises Price Target to $65

UBS analyst Doug Schenkel maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $52 to $65.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on Veracyte, Lowers Price Target to $54

Piper Sandler analyst David Westenberg maintains Veracyte (NASDAQ:VCYT) with a Overweight and lowers the price target from $66 to $54.

Benzinga Newsdesk

PRO
Stephens & Co. Maintains Overweight on Veracyte, Lowers Price Target to $55

Stephens & Co. analyst Mason Carrico maintains Veracyte (NASDAQ:VCYT) with a Overweight and lowers the price target from $68 to $55.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Underweight on Veracyte, Lowers Price Target to $44

Morgan Stanley analyst Tejas Savant maintains Veracyte (NASDAQ:VCYT) with a Underweight and lowers the price target from $47 to $44.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on Veracyte, Lowers Price Target to $50

Canaccord Genuity analyst Kyle Mikson maintains Veracyte (NASDAQ:VCYT) with a Hold and lowers the price target from $60 to $50.

Benzinga Newsdesk

PRO
Needham Maintains Buy on Veracyte, Raises Price Target to $69

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $57 to $69.

Benzinga Newsdesk